Emerging Technologies
VeriFact analyzes statements in AI-generated clinical text against patients’ EHRs to identify factual errors, achieving 93.2% agreement with clinicians.
The company will use the funds to accelerate commercialization of its brain-signal AI technology and expand its cognitive health applications.
Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.
The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring device.
Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.
Screening rates in northern Queensland lag behind the statewide average.
The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.
The company said the acquisition allows it to begin delivering a comprehensive stepped care model that incorporates group therapy and peer support.
Trained on local medical laws and treatment guidelines, the model scored 96.4 on the 2025 Korean Medical Licensing Examination.
The model can also make zero-shot predictions.